Potential implications for monitoring serum bile acid profiles in circulation with serum proteome for carbon tetrachloride-induced liver injury/regeneration model in mice

Journal of Proteome Research

Volumn 9, Issue 9, 2010, Pages 4490-4500

  Shimada, Takashi ^a   Nakanishi, Tsuyoshi ^a   Toyama, Atsuhiko ^a   Yamauchi, Satoshi ^b   Kanzaki, Atsuhiro ^b   Fujiwake, Hideshi ^a   Sato, Taka Aki ^a   Ikegawa, Masaya ^b  

^a SHIMADZU CORPORATION   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

bile acid; carbon tetrachloride; gene ontology; imaging mass spectrometry; mouse; serum proteomics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILE ACID CONJUGATE; CARBON TETRACHLORIDE; GLYCINE; PROTEOME; TAURINE; TAUROCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; HISTOPATHOLOGY; LIVER CIRCULATION; LIVER INJURY; LIVER REGENERATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; SOLID PHASE EXTRACTION;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARBON TETRACHLORIDE POISONING; DRUG-INDUCED LIVER INJURY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCINE; HISTOCYTOCHEMISTRY; LIVER REGENERATION; MALE; MICE; MICE, INBRED ICR; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAURINE; TAUROCHOLIC ACID;

MUS;

EID: 77956305956     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr1002388     Document Type: Article

References (35)

1. Hofmann, A. F.; Hagey, L. R. Bile acids: Chemistry, pathochemistry, biology, pathobiology, and therapeutics Cell. Mol. Life Sci. 2008, 65, 2461-2483
2. Lefebvre, P.; Cariou, B.; Lien, F.; Kuipers, F.; Staels, B. Role of bile acids and bile acid receptors in metabolic regulation Physiol. Rev. 2009, 89, 147-191
3. Shaham, O. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity Mol. Syst. Biol. 2008, 4, 214
4. Martin, F. P. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model Mol. Syst. Biol. 2007, 3, 112
5. Nguyen, A.; Bouscarel, B. Bile acids and signal transduction: role in glucose homeostasis Cell. Signalling 2008, 20, 2180-2197
6. Huang, W. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration Science 2006, 312, 233-236
7. Thomas, C.; Pellicciari, R.; Pruzanski, M.; Auwerx, J.; Schoonjans, K. Targeting bile-acid signalling for metabolic diseases Nat. Rev. Drug Discovery 2008, 7, 678-693
8. Lai, K. K.; Kolippakkam, D.; Beretta, L. Comprehensive and quantitative proteome profiling of the mouse liver and plasma Hepatology (Baltimore, MD) 2008, 47, 1043-1051
9. Parent, R.; Beretta, L. Proteomics in the study of liver pathology J. Hepatol. 2005, 43, 177-183
10. Amacher, D. E.; Adler, R.; Herath, A.; Townsend, R. R. Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy Clin. Chem. 2005, 51, 1796-1803
11. Craig, A. Systems toxicology: Integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat J. Proteome Res. 2006, 5, 1586-1601
12. Merrick, B. A. Alterations in the rat serum proteome during liver injury from acetaminophen exposure J. Pharmacol. Exp. Ther. 2006, 318, 792-802
13. Minami, K. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats Toxicol. Sci. 2005, 87, 296-305
14. Ozer, J.; Ratner, M.; Shaw, M.; Bailey, W.; Schomaker, S. The current state of serum biomarkers of hepatotoxicity Toxicology 2008, 245, 194-205
15. Bollard, M. E. NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat J. Proteome Res. 2010, 9, 59-69
16. Anderson, N. L.; Anderson, N. G. The human plasma proteome: History, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1, 845-867
17. Shinoda, K.; Sugimoto, M.; Tomita, M.; Ishihama, Y. Informatics for peptide retention properties in proteomic LC-MS Proteomics 2008, 8, 787-798
18. Burkard, I.; von Eckardstein, A.; Rentsch, K. M. Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry J. Chromatogr. 2005, 826, 147-159
19. Mims, D.; Hercules, D. Quantification of bile acids directly from urine by MALDI-TOF-MS Anal. Bioanal. Chem. 2003, 375, 609-616
20. Murphy, R. C.; Hankin, J. A.; Barkley, R. M. Imaging of lipid species by MALDI mass spectrometry J. Lipid Res. 2009, 50 (Suppl) S317-322
21. Quadroni, M.; James, P. Proteomics and automation Electrophoresis 1999, 20, 664-677
22. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4, 44-57
23. Brunt, E. M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond Hepatology (Baltimore, MD) 2000, 31, 241-246
24. LeSage, G. D. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver Hepatology (Baltimore, MD) 1999, 29, 307-319
25. Suhler, E.; Lin, W.; Yin, H. L.; Lee, W. M. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis Crit. Care Med. 1997, 25, 594-598
26. Uhlar, C. M.; Whitehead, A. S. Serum amyloid A, the major vertebrate acute-phase reactant Eur. J. Biochem. 1999, 265, 501-523
27. Tegoni, M. Mammalian odorant binding proteins Biochim. Biophys. Acta 2000, 1482, 229-240
28. Graham, T. E. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects N. Engl. J. Med. 2006, 354, 255-2563
29. Jungermann, K.; Kietzmann, T. Zonation of parenchymal and nonparenchymal metabolism in liver Annu. Rev. Nutr. 1996, 16, 179-203
30. Jones, A. L. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative Am. J. Physiol. 1980, 238, G233-237
31. Angelin, B.; Bjorkhem, I.; Einarsson, K.; Ewerth, S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum J. Clin. Invest. 1982, 70, 724-731
32. Zhang, Y.; Edwards, P. A. FXR signaling in metabolic disease FEBS Lett. 2008, 582, 10-18
33. Yamagata, K. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1 J. Biol. Chem. 2004, 279, 23158-23165
34. Matsuzaki, Y. Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver Biochim. Biophys. Acta 2002, 1588, 139-148
35. Falany, C. N.; Fortinberry, H.; Leiter, E. H.; Barnes, S. Cloning, expression, and chromosomal localization of mouse liver bile acid CoA:amino acid N-acyltransferase J. Lipid Res. 1997, 38, 1139-1148